Fundraising Fox

AtheroMed

Menlo Park, US · 3 known investors

Healthtech

Founders & leadership

CD
Chris DanekNamed on SEC filing
WM
Will McGuireNamed on SEC filing
DS
David SchulteNamed on SEC filing
CT
Casey TanseyNamed on SEC filing
AK
Alan KaganovNamed on SEC filing
TC
Tony ChouNamed on SEC filing

Investors · 3

Canaan PartnersStamford · $500K – $20M
Kaiser Permanente VenturesSan Francisco · $2M – $5M
US Venture PartnersMenlo Park · $500K – $10M

Reported raises · per SEC filings

Form D private placements

$4.5M disclosed across 1 round · 2012

▶$4.5MraisedMar 2012 · 21 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Chris DanekExecutive Officer
  • Will McGuireExecutive Officer, Director
  • David SchulteDirector
  • Casey TanseyDirector
  • Alan KaganovDirector
  • Tony ChouDirector
Offering amount
$4.5M
Amount sold
$4.5M
First sale
Mar 2012
Incorporated
Corporation, Delaware
Federal exemptions
06
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

AtheroMed to sacrifice itself to Volcano in $115m deal - Global Venturingglobalventuring.com · May 2014Stealthy AtheroMed raises $6M for peripheral atherectomy device - MassDevicemassdevice.com · Apr 2013

Frequently asked questions

Who are AtheroMed's investors?
AtheroMed's investors include Canaan Partners, Kaiser Permanente Ventures, US Venture Partners.
How much funding has AtheroMed raised?
AtheroMed has disclosed $4.5M raised across 1 round.
Where is AtheroMed headquartered?
AtheroMed is headquartered in Menlo Park, US.